1. Home
  2. JBIO vs GWRS Comparison

JBIO vs GWRS Comparison

Compare JBIO & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBIO
  • GWRS
  • Stock Information
  • Founded
  • JBIO 2024
  • GWRS 2003
  • Country
  • JBIO United States
  • GWRS United States
  • Employees
  • JBIO N/A
  • GWRS N/A
  • Industry
  • JBIO
  • GWRS Water Supply
  • Sector
  • JBIO
  • GWRS Utilities
  • Exchange
  • JBIO NYSE
  • GWRS Nasdaq
  • Market Cap
  • JBIO 290.1M
  • GWRS 283.3M
  • IPO Year
  • JBIO N/A
  • GWRS 2010
  • Fundamental
  • Price
  • JBIO $8.28
  • GWRS $10.17
  • Analyst Decision
  • JBIO Strong Buy
  • GWRS
  • Analyst Count
  • JBIO 2
  • GWRS 0
  • Target Price
  • JBIO $15.50
  • GWRS N/A
  • AVG Volume (30 Days)
  • JBIO 397.1K
  • GWRS 58.8K
  • Earning Date
  • JBIO 08-05-2025
  • GWRS 08-13-2025
  • Dividend Yield
  • JBIO N/A
  • GWRS 2.98%
  • EPS Growth
  • JBIO N/A
  • GWRS N/A
  • EPS
  • JBIO N/A
  • GWRS 0.23
  • Revenue
  • JBIO N/A
  • GWRS $53,539,000.00
  • Revenue This Year
  • JBIO N/A
  • GWRS $8.31
  • Revenue Next Year
  • JBIO N/A
  • GWRS $6.52
  • P/E Ratio
  • JBIO N/A
  • GWRS $44.39
  • Revenue Growth
  • JBIO N/A
  • GWRS 3.94
  • 52 Week Low
  • JBIO $1.61
  • GWRS $9.37
  • 52 Week High
  • JBIO $13.50
  • GWRS $13.98
  • Technical
  • Relative Strength Index (RSI)
  • JBIO N/A
  • GWRS 46.44
  • Support Level
  • JBIO N/A
  • GWRS $10.08
  • Resistance Level
  • JBIO N/A
  • GWRS $10.46
  • Average True Range (ATR)
  • JBIO 0.00
  • GWRS 0.28
  • MACD
  • JBIO 0.00
  • GWRS -0.01
  • Stochastic Oscillator
  • JBIO 0.00
  • GWRS 12.00

About JBIO JADE BIOSCIENCES INC

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

About GWRS Global Water Resources Inc.

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.

Share on Social Networks: